BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 24424059)

  • 1. Rosiglitazone inhibits expression and secretion of PEDF in adipose tissue and liver of male SD rats via a PPAR-γ independent mechanism.
    Yang S; Luo T; Zhou H; Lv Q; Liu L; Zhang W; Gao R; Chen S; Xia W; Luo M; Cheng Q; Li Q
    Endocrinology; 2014 Mar; 155(3):941-50. PubMed ID: 24424059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin inhibits expression and secretion of PEDF in adipocyte and hepatocyte via promoting AMPK phosphorylation.
    Yang S; Lv Q; Luo T; Liu L; Gao R; Chen S; Ye P; Cheng Q; Li Q
    Mediators Inflamm; 2013; 2013():429207. PubMed ID: 24288442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats.
    Kramer D; Shapiro R; Adler A; Bush E; Rondinone CM
    Metabolism; 2001 Nov; 50(11):1294-300. PubMed ID: 11699047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pigment epithelium-derived factor inhibits adipogenesis in 3T3-L1 adipocytes and protects against high-fat diet-induced obesity and metabolic disorders in mice.
    Chen CC; Lee TY; Leu YL; Wang SH
    Transl Res; 2019 Aug; 210():26-42. PubMed ID: 31121128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver, but not adipose tissue PEDF gene expression is associated with insulin resistance.
    Moreno-Navarrete JM; Touskova V; Sabater M; Mraz M; Drapalova J; Ortega F; Serrano M; Catalán V; Gómez-Ambrosi J; Ortiz MR; Pardo G; Pueyo N; Ricart W; Lacinova Z; Haluzik M; Frühbeck G; Fernández-Real JM
    Int J Obes (Lond); 2013 Sep; 37(9):1230-7. PubMed ID: 23318725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual regulation of adipose triglyceride lipase by pigment epithelium-derived factor: a novel mechanistic insight into progressive obesity.
    Dai Z; Qi W; Li C; Lu J; Mao Y; Yao Y; Li L; Zhang T; Hong H; Li S; Zhou T; Yang Z; Yang X; Gao G; Cai W
    Mol Cell Endocrinol; 2013 Sep; 377(1-2):123-34. PubMed ID: 23850519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pigment epithelium-derived factor contributes to insulin resistance in obesity.
    Crowe S; Wu LE; Economou C; Turpin SM; Matzaris M; Hoehn KL; Hevener AL; James DE; Duh EJ; Watt MJ
    Cell Metab; 2009 Jul; 10(1):40-7. PubMed ID: 19583952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmented expression and secretion of adipose-derived pigment epithelium-derived factor does not alter local angiogenesis or contribute to the development of systemic metabolic derangements.
    Lakeland TV; Borg ML; Matzaris M; Abdelkader A; Evans RG; Watt MJ
    Am J Physiol Endocrinol Metab; 2014 Jun; 306(12):E1367-77. PubMed ID: 24760990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum pigment epithelium-derived factor is elevated in women with polycystic ovary syndrome and correlates with insulin resistance.
    Yang S; Li Q; Zhong L; Song Y; Tian B; Cheng Q; Qing H; Xia W; Luo M; Mei M
    J Clin Endocrinol Metab; 2011 Mar; 96(3):831-6. PubMed ID: 21209034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosiglitazone, an agonist of peroxisome-proliferator-activated receptor gamma (PPARgamma), decreases inhibitory serine phosphorylation of IRS1 in vitro and in vivo.
    Jiang G; Dallas-Yang Q; Biswas S; Li Z; Zhang BB
    Biochem J; 2004 Jan; 377(Pt 2):339-46. PubMed ID: 14556646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.
    Díaz-Delfín J; Morales M; Caelles C
    Diabetes; 2007 Jul; 56(7):1865-71. PubMed ID: 17416798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F9 (4-(3,6-bis (ethoxycarbonyl)-4,5,6,7-tetrahydrothieno (2,3-c) pyridin-2-ylamino)-4-oxobutanoic acid) enhances insulin-mediated glucose uptake in vitro and exhibits antidiabetic activity in vivo in db/db mice.
    Anandharajan R; Sayyed SG; Doshi LS; Dixit P; Chandak PG; Dixit AV; Brahma MK; Deshmukh NJ; Gupte R; Damre A; Suthar J; Padigaru M; Sharma SD; Nemmani KV
    Metabolism; 2009 Oct; 58(10):1503-16. PubMed ID: 19608207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEDF expression is inhibited by insulin treatment in adipose tissue via suppressing 11β-HSD1.
    Zhou Y; Xu F; Deng H; Bi Y; Sun W; Zhao Y; Chen Z; Weng J
    PLoS One; 2013; 8(12):e84016. PubMed ID: 24367624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of insulin on pigment epithelium-derived factor expression in adipocytes of type 2 diabetic mellitus in rats].
    Xu F; Lin B; Zhou Y; Deng H; Bi Y; Liang H
    Zhonghua Yi Xue Za Zhi; 2014 Oct; 94(38):2992-5. PubMed ID: 25547701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.
    Svegliati-Baroni G; Saccomanno S; Rychlicki C; Agostinelli L; De Minicis S; Candelaresi C; Faraci G; Pacetti D; Vivarelli M; Nicolini D; Garelli P; Casini A; Manco M; Mingrone G; Risaliti A; Frega GN; Benedetti A; Gastaldelli A
    Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating pigment epithelium-derived factor levels are associated with insulin resistance and decrease after weight loss.
    Sabater M; Moreno-Navarrete JM; Ortega FJ; Pardo G; Salvador J; Ricart W; Frühbeck G; Fernández-Real JM
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4720-8. PubMed ID: 20631025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obese mice lacking inducible nitric oxide synthase are sensitized to the metabolic actions of peroxisome proliferator-activated receptor-gamma agonism.
    Dallaire P; Bellmann K; Laplante M; Gélinas S; Centeno-Baez C; Penfornis P; Peyot ML; Latour MG; Lamontagne J; Trujillo ME; Scherer PE; Prentki M; Deshaies Y; Marette A
    Diabetes; 2008 Aug; 57(8):1999-2011. PubMed ID: 18458147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosiglitazone reduces liver fat and insulin requirements and improves hepatic insulin sensitivity and glycemic control in patients with type 2 diabetes requiring high insulin doses.
    Juurinen L; Kotronen A; Granér M; Yki-Järvinen H
    J Clin Endocrinol Metab; 2008 Jan; 93(1):118-24. PubMed ID: 17956948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential insulin sensitizing and glucose lowering effects of a novel indole derivative in vitro and in vivo.
    Li YY; Wu HS; Tang L; Feng CR; Yu JH; Li Y; Yang YS; Yang B; He QJ
    Pharmacol Res; 2007 Oct; 56(4):335-43. PubMed ID: 17889553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platycodin D inhibits lipogenesis through AMPKα-PPARγ2 in 3T3-L1 cells and modulates fat accumulation in obese mice.
    Lee EJ; Kang M; Kim YS
    Planta Med; 2012 Sep; 78(14):1536-42. PubMed ID: 22872592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.